Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...

Title: Biparatopic anti-HER2 antibody drug conjugate (ADC) JSKN003 in the treatment of primary platinum-refractory ovarian cancer (OC) Presentation Number: 1079P Onsite Poster display date: Saturday, ...

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the ...

“DESTINY-Breast11 results support T-DXd [plus] THP as a more effective and less toxic neoadjuvant treatment compared with ddAC-THP, and it may become the preferred regimen for patients with high-risk, ...

On Oct. 6, more than 51,000 teachers across Alberta walked off the job after months of failed negotiations between the ...

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

AstraZeneca and Daiichi Sankyo’s star drug Enhertu has delivered a double knockout, showing its ability to stave off early ...

Many embedded Linux solutions exist. However, while free options are convenient, they can be challenging to manage since they ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and ...

Healthcare Trend Analysis Reveals Shift Toward Non-Invasive Pre-Surgical Evaluation as Multi-Modal Compression Technology Addresses Growing Patient Demand for Evidence-Based Alternatives ...

ADRE Grade 4 Result 2025: The Assam State Level Recruitment Commission has issued the ADRE Grade 4 Result 2025. Applicants ...

Private schools looking to educate participating students may also have a chance to apply to the program before the end of ...